SOUND PHARMACEUTICALS INC.

Address: 4010 STONE WAY N SEATTLE, WA 98103-8099
County: KING
Country: UNITED STATES
UEI: S8Q8EVXYLSN1

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2024 ( Subtotal = $0 )

2024

2022

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

001

NIH

1/8/2024

2024

2021

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

000

NIH

11/10/2023

2024

2021

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

002

NIH

6/13/2024

Issue Date FY: 2022 ( Subtotal = $1,092,161 )

2022

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N STE 120

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

001

NIH

5/12/2022

2022

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N STE 120

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

000

NIH

5/11/2022

$1,092,161

Issue Date FY: 2021 ( Subtotal = $3,082,804 )

2021

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N STE 120

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

001

NIH

4/17/2021

2021

SOUND PHARMACEUTICALS INC.

4010 STONE WAY N STE 120

SEATTLE

98103-8099

KING

USA

U01TR003853

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation studies to Evaluate the Safety and Efficacy of SPI-1005 in Moderate and Severe COVID-19 Patients

000

NIH

4/6/2021

$3,082,804

Issue Date FY: 2003 ( Subtotal = $160,000 )

2003

SOUND PHARMACEUTICALS INC

4010 STONE WAY NORTH

SEATTLE

98103

KING

USA

R43DC005928

CELLULAR REGENERATION IN THE ORGAN OF CORTI

000

NIH

$160,000

All Categories

About

Search

Reports

Data Submission

Recipient Information

SOUND PHARMACEUTICALS INC.

Address: 4010 STONE WAY N SEATTLE, WA 98103-8099

County: KING

Country: UNITED STATES

UEI: S8Q8EVXYLSN1

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer